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Adaptive genetic variability is vital to long-term species survival, as it presents the potential 
for evolutionary adaptive responses to environmental change. Genes of the Major 
Histocompatibility Complex (MHC) trigger the vertebrate adaptive immune response to 
pathogens through the recognition and presentation of foreign peptides, and thus provide an 
informative genetic marker for studying the adaptive potential of species with respect to 
disease. MHC class I loci mediate the immune system’s recognition of intracellular 
pathogens, including protozoans, viruses and bacteria, and the high levels of genetic diversity 
reported at these loci is thought to be primarily the result of pathogen-mediated selection. 
Although variation within a number of MHC genes has been described in many felid species, 
the relationship between MHC diversity and pathogen prevalence within wild felid 
populations has rarely been examined previously. Because many wild felids are highly 
sensitive to the effects of anthropogenic-induced environmental changes, evolutionarily 
relevant adaptive genetic variation is particularly important for their conservation. This study 
explored the relationship between MHC class I exon 2 and exon 3 diversity and a number of 
tick-borne blood pathogens in a population of caracal (Caracal caracal) in the urban 
landscape of Cape Town, South Africa. The characterization of MHC class I diversity 
identified 38 and 45 unique, putatively functional alleles in the population, from exon 2 and 
exon 3 respectively. The influence of MHC allelic diversity and specific alleles, together with 
sex, age class, home range size and urban cover within home range, on individual pathogen 
prevalence was assessed using Generalized Linear Models. A positive relationship between 
Babesia infection and multiple measures of MHC diversity, including nucleotide diversity, 
average number of nucleotide differences and number of exon 3 alleles, was detected. 
Additionally, the presence of two specific alleles was significantly correlated with Babesia 
infection. High levels of infection by a number of tick-borne pathogens were observed in the 
population, suggesting environmental factors also have an important influence on pathogen 
prevalence. However, home range and urban cover within home range, as well as sex and age, 
were not significantly associated with Babesia infection. This study provides the first 
assessment of the relationship between MHC class I adaptive genetic variation and individual 
pathogen prevalence in caracal. 




Adaptive genetic variation in a changing world 
Anthropogenic activities including urbanization, habitat alteration, and overexploitation, are 
increasingly impacting all levels of biological diversity, across the globe (Chapin et al. 2000; 
Crutzen & Stoermer 2000; Garner et al. 2005). In recent decades rapid human population 
growth, together with the associated expansion of urban areas, has accelerated the rate of 
environmental modification and subsequent loss of biodiversity (Vitousek et al. 1997; 
Ceballos et al. 2015). Habitat loss and fragmentation (Fahrig 2003), climate change (Thomas 
et al. 2004; Urban 2015), and shifting patterns of disease (Altizer et al. 2003) are among the 
effects of these anthropogenic activities, and pose significant extinction risks to many species. 
Anthropogenic-induced changes to natural populations also contribute to the loss of genetic 
diversity, an evolutionarily and ecologically important trait that can be monitored at the level 
of individuals, populations and species (Garner et al. 2005). In a changing world, the capacity 
for species to adapt is essential for their persistence (Lande & Shannon 1996; Meyers & Bull 
2002; Boutin & Lane 2014; Carlson et al. 2014). All evolutionarily adaptive responses to 
environmental fluctuations are ultimately dependent on genetic variation (Burger & Lynch 
1995; Lacy 1997; Hoffmann & Sgrò 2011; Hansen et al. 2012). Thus, genetic variability, and 
its conservation, is vital to adaptation and long-term species survival (Lande & Shannon 
1996; Lacy 1997; Frankham 2005; Pertoldi et al. 2007).  
Populations that experience rapid decline in numbers often undergo a concomitant loss of 
genetic variation, as quantified by measures of heterozygosity, general polymorphism and 
allelic diversity (Lande & Shannon 1996; Lacy 1997; Frankham 2005; Pertoldi et al. 2007). 
Losses of genetic variability can result from decreased gene flow, increased inbreeding 
and/or increased genetic drift through population fragmentation and increased genetic 
substructure (Stevens et al. 1997; Frankham 2005). The effects of such loss vary depending 
on the type of variation lost: neutral or adaptive (van Tienderen et al. 2002; Holderegger et al 
2006). Variation within neutral (non-coding) gene regions does not necessarily cause direct 
fitness effects, whereas the loss of adaptive genetic variation, i.e. variation under selection, 
can directly affect individual fitness. Reduced adaptive genetic variation can contribute to 
short-term decline in individual fitness (Roelke et al. 1993), as well as long-term decrease in 
a population’s adaptive potential (O’Brien et al. 1985; Lande & Shannon 1996; Lacy 1997; 
Meyers & Bull 2002; Frankham 2005), and thereby contribute to the general decline in the 
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size of a population. For example, the vulnerability of genetically homogeneous populations 
to widespread pathogen outbreaks is commonly recognized (Altizer et al. 2003; King & 
Lively 2012). Genetically similar individuals are more likely to transmit infections between 
themselves, while genetically dissimilar individuals are more likely to have resistant 
genotypes that can stop pathogens from multiplying, reproducing and/or spreading 
throughout a population (King & Lively 2012). Thus, genetic diversity plays a key role in 
individual disease resistance and in buffering populations against epidemics (Altizer et al. 
2003). The maintenance of adaptive genetic variation is thus critical for species conservation 
in a rapidly changing world undergoing habitat fragmentation, urban development, and 
shifting disease patterns (Lande & Shannon 1996; Lacy 1997; Sommer 2005).  
For the past two decades quantification of genetic variation at neutral markers has generally 
been the dominant focus of ecological studies (Sommer 2005; Holderegger et al. 2006). 
Because natural selection does not act upon these neutral markers, it is challenging to find 
causal associations between measures of neutral genetic variation and population and 
individual fitness however (Bekessy et al. 2003; Holderegger et al. 2006). Frequently utilized 
neutral gene markers include those within non-coding single nucleotide polymorphisms, 
together with microsatellite and minisatellite loci (van Tienderen et al. 2002; Holderegger et 
al. 2006). While these markers provide valuable information for population genetic, 
phylogeographic and phylogenetic reconstructions, they are limited for understanding 
selection pressures and adaptive potential (van Tienderen et al. 2002). Because coding 
markers are under selection (purifying, balancing and/or positive), variation within these 
regions reflects recent and historic adaptive and evolutionary processes, e.g. pathogen-
mediated selection on genes of the immune system (van Tienderen et al. 2002; Sommer 
2005). Coding-regions that are under positive selection can also reveal detectable changes 
over shorter timescales than neutral markers (van Tienderen et al. 2002). In vertebrates, the 
assemblage of genes that form the adaptive immune system, known as the Major 
Histocompatibility Complex (MHC) is amongst the most diverse in the vertebrate genome, 
and provides researchers with a highly informative region for the study of adaptive potential 
in declining and small populations (Sommer 2005; Spurgin & Richardson 2010; Blanchong 
et al. 2016). 
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Adaptive immune diversity of the MHC and its association with pathogens 
The adaptive immune system plays a crucial role in vertebrate defence against pathogen-
mediated diseases, and thereby the long-term persistence of populations and species 
(Spielman et al. 2004; Sommer 2005). As a subsystem of the overall immune system, the 
adaptive immune system specializes in differentiating ‘self’ from ‘non-self’ (foreign) 
molecules, and provides a mechanism for immunological memory of infections (Flajnik & 
Kasahara 2001). The MHC consists of a collection of closely linked genes that contribute to 
the adaptive immune system’s recognition of foreign pathogens (Simpson 1988; Edwards & 
Hedrick 1998; Flajnik & Kasahara 2001). MHC genes encode glycoprotein receptors, which 
bind and present peptides to T-lymphocytes on the surface of nucleated cells. When these 
receptors are bound to foreign pathogen-derived peptides, the adaptive immune system is 
signalled to initiate an appropriate immune response (Simpson 1988). MHC genes are 
divided into two main types, class I and class II, which mediate the immune system’s 
recognition and destruction of intracellular and extracellular pathogens respectively (Edwards 
& Hedrick 1998; Flajnik & Kasahara 2001). Pathogen and self-derived peptides are presented 
to the immune system by the receptor’s functionally important, peptide binding region 
(PBR); the PBR of class I cell surface receptors is encoded by two separate exons (exon 2 
and exon 3), while a single exon, exon 2, encodes the PBR of class II receptors. 
The MHC consists of multiple loci (polygenic) and multiple alleles (polymorphic) and is 
considered the most diverse gene family in vertebrates (Edwards & Hedrick 1998). The 
evolutionary pattern observed in the MHC is explained by the birth-and-death evolution 
model, which proposes that repeated gene duplication creates new genes, some of which 
remain in the genome, whereas others are deleted or inactivated through deleterious 
mutations (Nei & Rooney 2005). MHC alleles are bi-parentally inherited and co-dominantly 
expressed, generating high variation in number of alleles and level of heterozygosity within 
individuals (Simpson 1988). High diversity of MHC allele sequences within most natural 
populations is interpreted as an adaptation to resist infection by a wide range of pathogens, 
driven by pathogen-mediated (positive) selection (Simpson 1988; Yuhki & O’Brien 1990). 
Evidence supporting the influence of MHC loci on vulnerability to infectious diseases 
through pathogen-mediated selection has been reported for many species, such as the great 
reed warbler (Acrocephalus arundinaceus; Westerdahl et al. 2005), Atlantic salmon (Salmo 
salar; Lohm et al. 2002; Kjøglum et al. 2006), three-spined sticklebacks (Gasterosteus 
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aculeatus; Wegner et al. 2003a), pythons (Liasis fuscus; Madsen & Ujvari 2006), Soay sheep 
(Ovis aries; Paterson et al. 1998), mouse lemurs (Microcebus murinus; Schad et al. 2005), 
and raccoons (Procyon lotor; Ruiz-López et al. 2014).  
Two nonexclusive mechanisms have been proposed as drivers of this pathogen-mediated 
selection: heterozygote advantage and rare-allele advantage (Hedrick 2002; De Boer et al. 
2004). Heterozygote advantage (also described as the overdominance model) proposes that 
heterozygous individuals have the ability to recognize a wider variation of pathogen peptides 
than homozygous individuals (Hughes & Nei 1988; Yuhki & O’Brien 1990). Recognition of 
many pathogens promotes increased resistance to diseases and potentially higher relative 
fitness, thus creating an advantage for heterozygous individuals. A selective advantage for 
heterozygosity with new mutations suggests nonsynonymous codon substitution rates will 
exceed synonymous ones. This nucleotide substitution pattern was first observed within 
regions of MHC class I in humans and mice (Hughes & Nei 1988). In addition, many 
experimental studies report a significant influence of MHC heterozygosity on individual 
pathogen prevalence in wild populations (Wegner et al. 2003a; Westerdahl et al. 2005; 
Madsen & Ujvari 2006). However, mathematical models and stochastic simulations 
demonstrate that heterozygote advantage alone does not sufficiently explain the high levels of 
MHC polymorphism observed in vertebrates, providing support for the influence of 
additional selection pressures on the evolution of MHC diversity (De Boer et al. 2004). 
Another suggested mechanism of pathogen-mediated selection at the MHC occurs through 
rare-allele advantage via the mechanism of a co-evolutionary arms race (termed the Red 
Queen hypothesis; Van Valen 1977; Dawkins & Krebs 1979) between pathogens and their 
host’s defences (Ladle 1992). In the presence of rapidly evolving host immune systems, 
pathogens themselves experience strong selective pressure to continuously evolve in order to 
infect common host genotypes; this establishes an advantage for unique host genotype 
mutations. Through this mechanism (also termed negative frequency-dependent selection; 
Takahata & Nei 1990), specific alleles may be selected against when they occur frequently, 
and selected for when they are rare (Ladle 1992; Borghans et al. 2004). Because host-
pathogen interactions are significantly influenced by local environmental conditions the 
advantage of specific alleles is thought to vary across both spatial and temporal scales 
(Hedrick 2002; Zhang & He 2013). The influence of one or more specific alleles on pathogen 
resistance or susceptibility has been established for a number of MHC loci, in species such as 
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Soay sheep (Paterson et al. 1998), pythons (Madsen & Ujvari 2006), mouse lemurs (Schad et 
al. 2005) and house sparrows (Passer domesticus; Bonneaud et al. 2006; Loiseau et al. 2008). 
Reproductive mechanisms have also been proposed as complementary processes for 
upholding diversity at the MHC (Potts & Wakeland 1993; Penn & Potts 1999). For example, 
negative assortative mating, cued by odour, is thought to foster increased mating between 
individuals with different genotypes, which then encourages heterozygosity in offspring 
(Penn & Potts 1999). It is likely that multiple selection pressures act on MHC simultaneously 
(De Boer et al. 2004) and an intermediate level of MHC diversity may be optimal for 
individuals (Nowak et al. 1992; Wegner et al. 2003b). Due to its maintenance of high 
diversity and role in the adaptive immune system, MHC is highly likely to be critical to 
species’ adaptive responses to fluctuating and unpredictable pathogen environments (Altizer 
et al. 2003). Consequently, it has become the model system for studying the adaptive 
potential of species with respect to disease (Sommer 2005; Spurgin & Richardson 2010; 
Blanchong et al. 2016).  
Adaptation to shifting disease patterns  
Pathogen communities are one of the most important drivers of change within natural 
populations, influencing both population size and genetic composition over time and space 
(Altizer et al. 2003). Pathogens act as selective forces on host species, promoting the 
evolution of a wide range of cellular defence mechanisms and ultimately immunological 
resistance when exposed to a variety of pathogens (Altizer et al. 2003; Altizer et al. 2006). 
Immunogenetic diversity in host populations therefore contributes to an essential buffering 
mechanism against widespread disease outbreaks (Altizer et al. 2003). Changes in 
environmental conditions, e.g. habitat fragmentation and climate change, caused by 
anthropogenic activities, e.g. urbanization and globalization, can directly impact pathogen 
communities and patterns of disease outbreak (Daszak et al. 2000; Altizer et al. 2006). A 
number of recent studies suggest that new routes of exposure, driven by anthropogenic 
encroachment into wildlife areas and range-shifts induced by climate change (Harvell et al. 
2002; Hoffmann & Sgrò 2011), are subjecting host species to new pathogen environments 
(Altizer et al. 2003; Daszak et al. 2000). In fact, climate change is predicted to elicit large-
scale changes in behaviour, movement and phenology of both hosts and pathogens (Altizer et 
al. 2013). Yet such shifts in pathogen environments, as well as their drivers, remain relatively 
understudied in wild populations (Spielman et al. 2004). This is of concern given that many 
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wild populations are threatened by multiple pressures simultaneously (e.g. restricted ranges, 
habitat fragmentation and overexploitation), and thus particularly vulnerable to infectious 
diseases (Murray et al. 1999). In such cases, adaptive genetic diversity and potential for 
evolutionary response will become paramount for the persistence of wild animal populations. 
Mesocarnivores as indicators of trophic stability and related species trends 
Due to their natural occurrence at low densities and large range requirements, carnivores are 
especially susceptible to the negative genetic effects, and subsequent disease vulnerability, of 
anthropogenic activities (O’Brien 1985; Inskip & Zimmermann 2009). Barriers to dispersal, 
such as roads and urban development, limit gene flow in species that naturally maintain large 
territories (Riley et al. 2006; Serieys et al. 2014). Furthermore, declining carnivore 
populations are extremely vulnerable to the negative effects of inbreeding promoted by home 
range contractions that cause naturally outbreeding populations to become isolated and inbred 
(O’Brien et al. 1985; Roelke et al. 1993). In addition to impacting the genetic makeup of 
carnivore populations, these pressures can directly influence the patterns of exposure to 
pathogens and frequency of human-carnivore conflicts (Murray et al. 1999; Inskip & 
Zimmermann 2009). 
As human populations increasingly encroach on wild areas, the large range and dietary 
requirements of apex carnivores have led to increased conflict with humans in recent decades 
(Inskip & Zimmermann 2009). Persecutions by humans, in addition to habitat loss, has driven 
the decline and often complete removal of apex predators from many environments, 
especially in non-protected areas (Inskip & Zimmermann 2009; Prugh et al. 2009). One 
ecological outcome of the removal of apex predators is the increase of mesopredators, termed 
“mesopredator release”, where populations of medium-sized predators flourish in the absence 
of historical apex predators (Soulé et al. 1988; Prugh et al. 2009). Mesopredators are 
predators from middle trophic levels that typically prey on smaller-sized animals. Because 
many mesopredator species exploit a broad prey resource base, they have reached high 
densities in and around many urban areas (Inskip & Zimmermann 2009; Prugh et al. 2009). 
Growing mesopredator populations increasingly affect the abundance of species at lower 
trophic levels. As a result, mesopredators are gaining greater importance in the ecosystems in 
which they occur and may be critical to maintaining trophic stability in ecosystems where 
large apex predators no longer occur (Prugh et al. 2009). However, as mesopredator 
populations grow, they face challenges related to fragmented and isolated habitat patches, 
 9 
and exposure to the novel pressures of urban environments, including novel pathogens, 
disease outbreaks, poisons and conflict with humans (Prugh et al. 2009).  
Infectious diseases are particularly threatening to urban mesocarnivore populations of 
conservation concern that have been left vulnerable by other factors such as range restriction 
and over-exploitation (Murray et al. 1999). In such cases, otherwise minor diseases can 
potentially devastate already declining populations. Additionally, due to their large home 
ranges, many carnivores traverse urban-rural boundaries on a regular basis, increasing their 
exposure to pathogen threats from both environments (Gehrt et al. 2010). Because many 
urban environments are associated with particularly high tick loads, tick-borne blood 
pathogens are a significant threat to urban and peri-urban mesocarnivores (Gehrt et al. 2010; 
Bevins et al. 2012; Rizzoli et al. 2014; Mackenstedt et al. 2015). A single tick can carry 
multiple disease-causing agents simultaneously and these pathogens can be transmitted by a 
wide variety of host types (Gilbert et al. 2001). Indeed, many pathogens found in wild 
populations have been transmitted from domestic animal hosts (Murray et al. 1999). Thus, 
mesocarnivores with large home ranges and/or large urban area cover within home ranges 
may have a higher risk of exposure to ticks and tick-borne pathogens (Riley et al. 2004; Gehrt 
et al. 2010; Rizzoli et al. 2014). 
In the face of contemporary ecological pressures, including infectious diseases, the detection 
of genetic and population trends for mesocarnivores can provide valuable indicators of 
related trends in many other species that are similarly threatened. One such mesocarnivore is 
the caracal (Caracal caracal), a medium-sized felid distributed across Africa, the Middle 
East and southwestern Asia (Avenant & Nel 1998; Macdonald & Loveridge 2010). Due to its 
wide geographical distribution, caracal within different environments face a range of threats 
with varying intensities, causing local population trends to differ. Caracal are mainly solitary 
and typically occupy large territories; males maintain territories that can be up to three times 
larger than female territories (Avenant & Nel 1998). Like other carnivores, their wide home 
ranges leave caracal vulnerable to the effects of anthropogenic activities that limit, modify 
and isolate their natural movement; these effects include loss of genetic diversity, high levels 
of mortality via road deaths and persecution, together with exposure to rodenticide poisons 
and emerging diseases (Serieys et al. 2014). Indeed, a recent review of worldwide patterns in 
human-felid conflict identified human conflicts as the most significant threat to regional and 
local caracal conservation throughout its range (Inskip & Zimmermann 2009). In the face of 
 10 
such a variety of threats, knowledge of genetic trends and adaptive potential could be 
valuable to inform conservation and management strategies for caracal and other emerging 
mesopredators (Lacy 1997). 
MHC variation and pathogens in urban caracal  
Population trends in patterns of adaptive genetic variation have been studied in many 
carnivore and mesopredator species. Numerous studies have quantified MHC variation within 
natural populations of wild felids, including characterization of MHC class II loci in species 
such as cheetah (Acinonyx jubatus; Castro-Prieto et al. 2011a), Bengal tiger (Panthera tigris; 
Pokorny et al. 2010) and Eurasian lynx (Lynx lynx; Wang et al. 2009). However, few studies 
of felid populations have characterised variation in MHC class I loci, and studies that have 
explored the relationship between MHC variation and pathogen infection are often limited by 
small sample size (Castro-Prieto et al. 2011a; 2011b). For example, a study by Addie et al. 
(2004) failed to detect a significant association between MHC class II loci and feline 
infectious peritonitis in domestic cats (Felis catus), but referred to small sample size as a 
possible explanation for this. Other studies that have suggested an association between felid 
MHC variation and disease susceptibility have only used indirect measurements (e.g. 
allograft rejection experiments in captive cheetah; O’Brien et al. 1985). Research that directly 
explores the influence of MHC gene diversity on pathogen prevalence will clearly contribute 
to a more nuanced understanding of disease vulnerability in the modified environments urban 
carnivores inhabit.  
This study examines the relationship between MHC class I genetic variability and 
intracellular tick-borne pathogen prevalence within an urban population of caracal in the city 
of Cape Town, South Africa. Pathogen prevalence varies substantially between caracal 
populations across South Africa, likely influenced by the varying land uses and 
environmental pressures surrounding distinct populations (S. Viljoen, unpublished data from 
ongoing MSc study). Caracal from Cape Town navigate a heavily fragmented and 
transformed urban environment, in which there are barriers to gene flow and numerous 
urban-associated, disease-transmitting species, like squirrels, pigeons and domestic pets. The 
prevalence of tick-borne pathogens among caracal in Cape Town is significantly higher than 
that of caracals in both natural protected areas and agricultural landscapes (S. Viljoen, 
unpublished data). These tick-borne blood pathogens include Hepatozoon felis, Babesia felis, 
Babesia leo, Babesia venatorum and Anaplasma species, which cause a range of diseases, 
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including hepatozoonosis, babesiosis and anaplasmosis (Averbeck et al. 1990; Penzhorn et al. 
2001; Penzhorn et al. 2004). These diseases significantly affect individual fitness by means of 
immune suppression, fever, appetite-loss, fatigue and anaemia (Schoeman et al. 2001; 
Bosman et al. 2007; Kumar et al. 2008).  
Genetic variation at exon 2 and exon 3 of MHC class I loci together with the prevalence of a 
number of important blood pathogens was examined in 26 caracal individuals occurring in 
and around the metropole of the city of Cape Town. DNA and amino acid sequence variation 
at exon 2 and exon 3 was characterised and a Generalized Linear Model framework was used 
to explore the influence of (i) allelic richness, (ii) sequence diversity and (iii) specific alleles 
on individual pathogen prevalence. The impacts of urban land use and home range size 
(calculated from GPS collar data), as well as sex and age class, were also investigated as 
contributing factors to the role of MHC gene diversity on patterns of pathogen infection. 
Understanding all potential drivers of pathogen infection can provide valuable insight into the 
adaptive potential of populations in rapidly changing landscapes. This study provides the first 






This study contributes to an ongoing program of research by the Urban Caracal Project 
(urbancaracal.org) at the University of Cape Town (UCT), and makes use of caracal blood 
samples collected during field sampling and collaring of individuals in Cape Town, South 
Africa. Whole blood samples (10-30 ml) were drawn from the saphenous vein of 
anaesthetised, live-trapped animals that were ear-tagged and radio-collared. Samples were 
collected from 26 individuals (Table 1), from December 2014 to October 2016, and stored at 
-80°C before processing. All sample collection from captured animals was conducted under 
the supervision of a qualified veterinarian, with ethical approval and appropriate permits from 
the University of Cape Town Science Faculty Animal Ethics Committee (2014/V20/LS), 
SANParks (2014-2017/CRC/2014-017) and Cape Nature (AAA007-00147-0056).  
Individual radio-collars were programmed to collect GPS locations during a period ranging 
from three weeks to six months. Locations were recorded with two different fix schedules; 
beginning at three-hour intervals throughout the 24-hour cycle, followed by 20-minute 
intervals every 9-10th day, for 24-36 hours. Home ranges were calculated based on three-
hour fixes by L. Serieys, for 21 study individuals (Table 1), using LoCoH (Getz et al. 2007). 
A percentage estimate of urban land use within each home range polygon was calculated by 
referencing the most recent available urban land use boundary data (City of Cape Town, 
2012). Home range calculations were not obtainable for the remaining five study individuals 




Table 1. Summary of the study caracal individuals from Cape Town, South Africa. Sex, age class 
(Ad = adult, Sub = sub-adult, Kit = kitten), home range size (km2), urban area use within home 
range (km2) and pathogen presence/absence data is reported for each individual. Pathogens 
were identified to genus. A dash indicates lack of data. 
DNA extraction and PCR detection of pathogens 
PCR optimisation and initial pathogen screening for 13 of the 26 study individuals was 
carried out by S. Viljoen (UCT) in 2015-2016. The remaining 13 individuals were screened 
as part of this study. Genomic DNA was extracted from whole blood samples using a 
DNeasy Blood and Tissue Kit (Qiagen, Germany) and stored at 4°C during processing. Using 
primers that target gene regions from a selection of tick-borne pathogens, multiple PCRs 
were performed with genomic DNA from each individual, displayed in Table 2. All PCRs 
were carried out on an Applied Biosystems 2720 Thermal Cycler (Applied Biosystems, USA). 
Reactions using RLB (Gubbels et al. 1999) and BTF (Jefferies et al. 2007) primer sets 
Individual Sex Age Home range 
Urban 
area Hepatozoon Babesia Anaplasma Mycoplasma 
C1 M Ad 76 3.87 0 1 1 0 
C2 F Ad 3.5 - 0 1 1 0 
C3 F Ad 10 0.44 0 1 1 0 
C4 M Ad 105 7.30 0 1 1 0 
C5 - Kit - - 1 0 1 0 
C6 M Ad 76 12.10 0 1 1 0 
C7 M Sub 22 10.91 0 1 1 0 
C8 M Sub 6 1.30 0 1 1 0 
C9 F Ad 19 2.81 0 1 1 0 
C10 M Ad 55 6.95 0 1 1 0 
C11 M Sub 22 2.63 0 1 1 0 
C12 M Ad 105 27.02 0 1 1 0 
C13 F Ad 20 3.48 0 1 1 0 
C16 M Ad 82 12.88 0 1 1 0 
C17 M Ad 50 9.08 0 1 1 0 
C18 M Sub 202 2.22 0 0 1 0 
C19 F Ad 10 9.79 0 1 1 0 
C20 M Ad 14 10.55 0 1 0 1 
C21 M Sub 35 8.12 0 1 1 0 
C22 F Sub 7 0.29 0 1 1 0 
C24 F Ad 30 0.02 0 1 1 0 
C25 M Ad 102 0 0 1 1 0 
C26 M Ad - - 0 0 1 0 
C27 F Ad - - 0 1 1 0 
C28 F Ad - - 0 1 1 0 
C29 M Ad - - 0 1 0 0 
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consisted of 0.5 µl of forward and reverse 10 µM primers, 4 µl extracted DNA, 12.5 µl 
Dream Taq Green PCR Master Mix (ThermoScientific ™, South Africa) and 7.5 µl ultrapure 
water (ddH2O). Reactions with the Ehr primer set (Bekker et al. 2002; Matjila et al. 2008) 
contained 0.5 µl of each 10 µM primer, 2 µl extracted DNA, 12.5 µl Dream Taq Green PCR 
Master Mix and 9.5 µl ddH2O. All amplified products were visualized using 1% agarose gels, 
under UV light. Samples that amplified a band of the expected size (based on the primers’ 
target) were considered positive. Positive samples were sequenced at the Central Analytical 
Facility, University of Stellenbosch, South Africa.  
Table 2. Primers used for detection of tick-borne pathogens, through PCR screening. PCR 
protocols used for each primer set are detailed. 
Target Primer name 5'-3' sequences 
PCR protocols 
No. of 
cycles Temp (°C) Time 
Babesia/Theileria      
18S rRNA 
RLB-F GAC ACA GGG AGG TAG 
TGA CAA G 1 
94 10 min 
 94 20 s 
(Gubbels et al. 1999) RLB-R CTA AGA ATT TCA CCT 
CTG ACA GT 2 
67 30 s 
  72 30 s 
   
2 
Repeat at 65, 
63, 61, 59, 57 
20, 30, 
30 s 
    1 72 7 min 
Babesia/Theileria/ 
Hepatozoon 18S rRNA 
BTF1 GGC TCA TTA CAA CAG 
TTA TAG 1 
94 3 min 
 58 1 min 
(Jefferies et al. 2007) BTR2 GGA CTA CGA CGG TAT 
CTG ATC G 
72 2 min 
  
35 
94 30 s 
   58 20 s 
   72 30 s 
      1 72 7 min 
Ehrlichia/Anaplasma 
16S rRNA 
Ehr-F  GGA ATT CAG AGT TGG 
ATC MTG GYT CAG 
1 95 2 min 
!
35 
95 30 s 
(Bekker et al. 2002;  Ehr-R  CGG GAT CCC GAG TTT 




Matjila et al. 2008)  30 s 
       1  72 10 min 
Samples indicating the presence of multiple infections from related species (with multiple 
peaks at identical positions in the sequence chromatogram) were cloned using the pGEM®-T 
Easy Vector System I (Promega, Madison, WI, USA) and JM109 Escherichia coli cells 
(Promega, Madison, WI, USA). Blue-white screening was used to identify positive clones on 
LIAX (Luria broth, 100 mM IPTG, 100mg/mL Ampicillin, 3% X-gal in dimethylformamide) 
agar plates. Five to ten positive colonies, and one negative colony, were selected for PCR 
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amplification with M13 primers designed to amplify the target insertion section of the vector. 
Reactions with the M13 forward (5’-GTA AAA CGA CGG CCA GT- 3’) and reverse (5’-
CAG GAA ACA GCT ATG AC-3’) primers followed cycling conditions of: 95°C for 2 min, 
35 cycles of 95°C for 30 s, 50°C for 20 s, 72°C for 40 s, and 72°C for 10 min. Each colony 
reaction contained 1 µl of 0.1 pmol/µl forward and reverse primers, 10 µl of Dream Taq 
Green PCR Master Mix (ThermoScientific ™, South Africa) and ddH20, to a total volume of 
20 µl. Again, successful amplifications were sent offsite to be sequenced. 
Screening of MHC class I variation 
Genomic DNA extracted from whole blood samples was also used to amplify exon 2 and 
exon 3 of MHC class I loci, using felid-specific primers from Smith & Hoffman (2001). 
Primers were designed to the adjacent intron regions (Figure 1) and PCR products were 
approximately 800 base pairs: exon 2 forward primer (5’-GGGAGCCCCGCTTCATCG-3’) 
and exon 3 reverse primer (5’-CGTCTCCTTCCCCATGTCC-3’) (Smith & Hoffman 2001). 
PCR conditions were as follows: initial denaturing at 94°C for 3 min, followed by 40 cycles 
of 1 min denaturation at 94°C, 2 min at 64°C, 2 min extension at 72°C, and ending with a 
final extension for 7 min at 72°C. PCR reactions contained 1 µl of diluted (1/10) genomic 
DNA, 0.5 µl of forward and reverse primers (at 50 pmol/µl), 12 µl of Dream Taq PCR Master 
Mix (ThermoScientific ™, South Africa) and ddH20, to a total volume of 25 µl. Following 
visualization by gel electrophoresis on 1% agarose gels, positive amplifications were excised 
and cleaned up with the Wizard® SV Gel and PCR Clean-Up System (Promega, Madison, 
WI, USA). 
Because gene duplication and extensive allelic diversity characterize MHC class I and class II 
loci, individual variation was determined using cloning and sequencing. PCR products were 
cloned using the pGEM®-T Easy Vector System I (Promega, Madison, WI, USA) with 
JM109 E. coli cells (Promega, Madison, WI, USA); and blue-white screening was used to 
identify positive clones on LIAX agar plates. Twelve to fifteen positive colonies were 
selected for colony PCR amplification and sequencing with plasmid specific primers (M13 
forward: 5’-GTA AAA CGA CGG CCA GT- 3’ and M13 reverse: 5’-CAG GAA ACA GCT 
ATG AC-3’), following the protocols previously described. 
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Figure 1. Schematic representation of a section of an MHC class I gene. Arrows indicate the 
location of the primers used in this study. The exon 2 and exon 3 coding sequences include the 
antigen-binding region of MHC class I molecules.  
Assessing MHC class I diversity and testing selection 
Sequence chromatograms were checked and manually edited in BioEdit v.7.2.5 (Hall 1999).  
Sequences were trimmed to include the coding regions of MHC class I exon 2 and exon 3, 
which were identified by alignment with published caracal sequences (Genbank accessions: 
AF283072, AF283078, AF283089, AF283095; Smith & Hoffman 2001). Sequences were 
aligned using the Clustal W alignment algorithm (Chenna et al. 2003) implemented in 
BioEdit, using default options. The number of unique sequences for each individual and the 
population was calculated using DNAsp v5.10 (Librado & Rozas 2009). To avoid 
overestimation of allelic diversity due to rare sequencing errors only alleles found in more 
than one individual and with at least two nucleotide differences were counted as unique, 
presumably functional alleles. Alleles were considered pseudo genes if the same premature stop 
codon(s) or disrupted reading frame(s) occurred within a sequence of more than one individual. 
These sequences were excluded from further analyses. Additional measures of diversity (gene 
diversity, nucleotide diversity and average number of nucleotide differences) were calculated 
for each individual and the population’s allele repertoire using DNAsp v5.10 (Librado & 
Rozas 2009). 
The phylogenetic placement of the caracal MHC class I sequences isolated in this study was 
determined using the neighbour-joining method as implemented in MEGA v6.0 using the 
Tamura-Nei model (Kumar et al. 2016). Branch support was evaluated by 1,000 bootstrap 
replicates.!Additional exon 2 and exon 3 sequences available for a number carnivore species 
were sourced from Genbank (Appendix A and B) and aligned using the Clustal W algorithm 
(Chenna et al. 2003) in BioEdit using default options. 
Amino acid sequences were deduced and functionally significant amino acids within the 
peptide binding region were identified through alignment with published domestic cat MHC 
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class I exon 2 and exon 3 sequences (Accessions: AF283068, AF283075, AF283085 
AF283092; Smith & Hoffman 2001) and caracal MHC class I exon 2 and exon 3 sequences 
(Accessions: AF283072, AF283078, AF283095, AF283089; Smith & Hoffman 2001). To 
test for positive selection in the final data set for each exon, the ratio of non-synonymous to 
synonymous substitutions in the amino acid alignments was calculated. A higher ratio of non-
synonymous (dN) substitutions relative to synonymous (dS) ones provides evidence for 
positive selection, i.e. ω = dN/dS > 1. These ratios were compared for the entire MHC class I 
exon 2 and exon 3 sequences, the PBRs only, and the non-PBRs only. Calculations were 
made with a modified (Jukes-Cantor) Nei-Gojobori method (Nei & Gojobori 1986) in MEGA 
v6.0 (Kumar et al. 2016), using 1,000 bootstrap replicates.  
Statistical Analysis 
The relationship between MHC class I diversity and pathogen prevalence was analysed using 
a Generalized Linear Model (GLM) framework in R v3.3.2 (R Development Core Team 
2016). Due to a lack of sufficient variation in individual pathogen prevalence across the 
population, as well as limited sample size, analyses were conducted using a univariate 
approach. Binomial GLMs were used to explore the effect of (i) the number of MHC class I 
alleles and (ii) diversity within alleles on the presence/absence of Babesia in individual 
caracal. Because the population’s allele frequency distribution for both exons showed one or 
two very common alleles and numerous rare alleles, the analysis for the role of specific 
alleles was limited to three alleles in order to permit the detection of statistically significant 
results. The GLMs implemented explored the association between the presence/absence of 
these alleles and Babesia infection. Additional GLMs were used to analyse the effect of sex, 




Characterization of MHC class I exon 2 and exon 3 diversity 
From the 312 clone sequences examined, 41 unique alleles were identified in the MHC class 
I exon 2 (Figure S1). Three non-functional alleles, considered pseudogenes, were excluded 
from further analysis due to the presence of stop codons in the amino acid translations 
(Figure 2). Thus, 38 unique, putatively functional exon 2 alleles were identified in the 
population sample of 26 individuals. Each individual had between two and six functional 
alleles (mean = 3.2 ± 1.3 SD), suggesting a minimum of three functional loci present. 
Measures of genetic diversity within the allele repertoire of exon 2, as well as exon 3, are 
displayed in Table 3. 
The assessment of exon 3 sequences revealed 65 unique alleles in the population (Figure S2), 
eight of which included stop codons in the amino acid translations (Figure 3). An additional 
12 sequences had a nucleotide deletion that resulted in a frame shift mutation, and likely 
represents a pseudogene. A BLAST analysis identified high affinity to a pseudogene 
sequence isolated from a tissue expression study in domestic cat (Accession: KC763055; 
Holmes et al. 2013). Further analysis of cDNA is, however, required to confirm this, as a 
number of non-classical MHC loci are also known in mammals (Pratheek et al. 2014). These 
sequences were also removed from further analysis, resulting in a total of 45 unique, 
putatively functional alleles at exon 3. Between two and seven putatively functional alleles 
(mean = 4.2 ± 1.8 SD) were detected in each individual from the sample population (Table 3), 
suggesting at least four putatively functional loci based on the MHC exon 3 sequences in 
caracal.  
Table 3. Summary of MHC class I exon 2 and exon 3 diversity measures* for the caracal sample 
population (n = 26) from Cape Town, South Africa.  
 
D A Pseudo 





Avg. no. of 
nucleotide 
differences 






Exon 2 41 38 Yes 2 - 6 0.99 0.06 11.4 6.2 10.2 
Exon 3 65 45 Yes 2 - 7 1.0 0.07 14.5 8.7 11.9 
*D = no. of detected unique alleles; A = no. of unique, putatively functional alleles; Pseudo = 
presence of pseudogenes; Pi = nucleotide diversity; and amino acid divergence = average 
number of amino acid codon differences/total number of amino acid codons. 
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                                 10        20        30        40        50        60            
                         ....|....|....|....|....|....|....|....|....|....|....|....|.. 
                                         +                ++  ++  +  ++  + +++       + 
Caca-MHCIexon2*01        DDTQFVRFDTDAPNPRMEPRAPWMEQVGPEYWDRETRIAKVHAEIARPNLQTALRYYNQSES  
Caca-MHCIexon2*02        G.............................................................  
Caca-MHCIexon2*03        .V.....................................................C......  
Caca-MHCIexon2*04        .G................................................R...........  
Caca-MHCIexon2*05        ........................G.........................R...........  
Caca-MHCIexon2*06        ..A.......G...............................T...................  
Caca-MHCIexon2*07        ..........................................S...................  
Caca-MHCIexon2*08        .....E...S....................................................  
Caca-MHCIexon2*09        .........A....................................................  
Caca-MHCIexon2*10        .............S................................................  
Caca-MHCIexon2*11        .............S................................................  
Caca-MHCIexon2*12        .............D................................................  
Caca-MHCIexon2*13        ..................L...........................................  
Caca-MHCIexon2*14        ................................N.............................  
Caca-MHCIexon2*15        .........................................R....................  
Caca-MHCIexon2*16        ...........................................G..................  
Caca-MHCIexon2*17        ................................................D.............  
Caca-MHCIexon2*18        ......................................................L.......  
Caca-MHCIexon2*19        .......................................................H......  
Caca-MHCIexon2*20        ....................................................T......N..  
Caca-MHCIexon2*21        .........................................................D..V.  
Caca-MHCIexon2*22        ............................................................G.  
Caca-MHCIexon2*23        ..............................................................  
Caca-MHCIexon2*24        ..............................................................  
Caca-MHCIexon2*25        ..............................................................  
Caca-MHCIexon2*26        ..............................................................  
Caca-MHCIexon2*27        .........S....................................................  
Caca-MHCIexon2*28        .........S....................................................  
Caca-MHCIexon2*29        .........S.......................................P............  
Caca-MHCIexon2*30        .........S................E...................................  
Caca-MHCIexon2*31        ..........................E......Q...NV.NW.Q.S.VD.N.M.........  
Caca-MHCIexon2*32        ..A.......................E......Q...NV.NW.Q.S.VD.NAM.........  
Caca-MHCIexon2*33        .........S................E......Q.A.NV.NW.Q.S.VD.N.M.........  
Caca-MHCIexon2*34        .........S................E......Q...NV.NW.Q.S.VD.N.M.H.......  
Caca-MHCIexon2*35        .........S................E......Q...NV.NW.Q.S.VD.N.M........P  
Caca-MHCIexon2*36        .........S................E......Q...NV.NW.Q.S.VD.N.M.........  
Caca-MHCIexon2*37        .........S................E......Q...NV.NW.Q.S.VD.N.M.........  
Caca-MHCIexon2*38        .........S................E......Q...NV.NR.Q.S.VD.N.M.........  
Caca-MHCIexon2-pseudo*01 .........S................E......Q...NV.N*.Q.S.VD.N.M.........  
Caca-MHCIexon2-pseudo*02 .........................*....................................  
Caca-MHCIexon2-pseudo*03 ..............................................*.D.............  
Figure 2. Amino acid translations of the unique MHC class I exon 2 alleles detected in this study. 
Dots and single letters designate nucleotide bases identical to and different from the first allele 
respectively. Asterisks represent stop codons. Sites with a + indicate previously reported 
functionally important amino acids within the peptide binding region of MHC class I receptors 
(Yuhki & O’Brien 1994; Smith & Hoffman 2001). !
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                             10        20        30        40        50        60        70              
                         ....|....|....|....|....|....|....|....|....|....|....|....|....|....|... 
                           +  +       +         + +        +  +                          ++     + 
Caca-MHCIexon3*01        GSHSIQRMHGCDIGPDGRLLRGYSQLAYDGADYIALNEDLRSWTAADTAAQITRRKWEVAGEAARYRKYLEDT 
Caca-MHCIexon3*02        E..............V.........................................................  
Caca-MHCIexon3*03        .P.......................................................................  
Caca-MHCIexon3*04        ...G.....................................................................  
Caca-MHCIexon3*05        .....R...................................................................  
Caca-MHCIexon3*06        .......I.................................................................  
Caca-MHCIexon3*07        .......I...............G.................................................  
Caca-MHCIexon3*08        .......................G.................................................  
Caca-MHCIexon3*09        ...........N...................................................V.........  
Caca-MHCIexon3*10        ...........G...................................................V.........  
Caca-MHCIexon3*11        ................................................T..............V.........  
Caca-MHCIexon3*12        ...............................................................V.........  
Caca-MHCIexon3*13        ..........................................................E....V.........  
Caca-MHCIexon3*14        .............................S.................................V.........  
Caca-MHCIexon3*15        ..............S..........................................................  
Caca-MHCIexon3*16        ...........................H............................................M  
Caca-MHCIexon3*17        ............................G............................................  
Caca-MHCIexon3*18        .............................D...........................................  
Caca-MHCIexon3*19        ..............................G.....................................H....  
Caca-MHCIexon3*20        ..................................T........................V.............  
Caca-MHCIexon3*21        ...........................................................V.............  
Caca-MHCIexon3*22        ...........................................................V.............  
Caca-MHCIexon3*23        .........................................P...............................  
Caca-MHCIexon3*24        ..........................................R..............................  
Caca-MHCIexon3*25        .......................................................R.................  
Caca-MHCIexon3*26        .......................................................E.................  
Caca-MHCIexon3*27        .....................................................H...................  
Caca-MHCIexon3*28        ..............................................................V..D.......  
Caca-MHCIexon3*29        ......................................................................... 
Caca-MHCIexon3*30        .......................................................................G.  
Caca-MHCIexon3*31        ...N..WTY................................................................  
Caca-MHCIexon3*32        ...N..WTY..........................................................E.....  
Caca-MHCIexon3*33        .........................VS...K...S..K...................................  
Caca-MHCIexon3*34        ...N..WTY................VS...K...S..K...................................  
Caca-MHCIexon3*35        ...N..WTY................VS...K...S..K....................E.CV...........  
Caca-MHCIexon3*36        ...N..WTY................VS...K...S..K....................E.CV.EDV.N...G.  
Caca-MHCIexon3*37        ...N..WTY................VS...K...S..K....................E.CV.EDI.N...G.  
Caca-MHCIexon3*38        ...N..WTY.R..............VS...K...S..K....................E.CV.EDI.N...G.  
Caca-MHCIexon3*39        ...N..WTY......G.........VS...K...S..K....................E.CV.EDI.N...G.  
Caca-MHCIexon3*40        ...N..WTY................VSH..K...S..K....................E.CV.EDI.N...G.  
Caca-MHCIexon3*41        ...N..WTY................VS...K.H.S..K....................E.CV.EDI.N...G.  
Caca-MHCIexon3*42        ...N..WTY................VS...K...S..K.P...A..............E.CV.EDI.N...G.  
Caca-MHCIexon3*43        ...N..WTY................VS...K...S..K.............T......E.CV.EDI.N...G.  
Caca-MHCIexon3*44        ...N..WTY................VS...K...S..K................H...E.CV.EDI.N...G.  
Caca-MHCIexon3*45        ...N..WTC................VS...K...SP.K....................E.CV.EDI.N...G. 
Caca-MHCIexon3-pseudo*01 .........................*..........S.................................... 
Caca-MHCIexon3-pseudo*02 ...N..WTY................VS...K...S..K.....DRGGHRGADHTPQVGGGR*GGAL*EVPGGH  
Caca-MHCIexon3-pseudo*03 ...........................................................GR*GGAL*EVPGGH  
Caca-MHCIexon3-pseudo*04 ...........................................DRGGHRGADHTPQVGGGR*GGAL*EVPGGH  
Caca-MHCIexon3-pseudo*05 ...............................G...........DRGGHRGADHTPQVGGGR*GGAL*EVPGGH  
Caca-MHCIexon3-pseudo*06 ......................C....................DRGGHRGADHTPQVGGGR*GGAL*EVPGGH  
Caca-MHCIexon3-pseudo*07 ...........................................DRGGHRGADHTPQVGGGR*GGAL*EVPGGH  
Caca-MHCIexon3-pseudo*08 ..R........................................DRGGHRGADHTPQVGGGR*GGAL*EVPGGH  
Caca-MHCIexon3-pseudo*09 ....................................S..................SGRWPVRRRAIGSTWRTR  
Caca-MHCIexon3-pseudo*10 ....V...............................................S..SGRWPVRRCAIGSTWRTR  
Caca-MHCIexon3-pseudo*11 .......................................................SGRWPVRRRAIGSTWRTR  
Caca-MHCIexon3-pseudo*12 .......................................................SGRWPVRRCAIGSTWRTR  
Caca-MHCIexon3-pseudo*13 ..L....................................................SGRWPVRRRAIGSTWRTR  
Caca-MHCIexon3-pseudo*14 .......................................................SGRWPVRRRAIGSTWRTR  
Caca-MHCIexon3-pseudo*15 ...........................H...........................SGRWPVRRRAIGSTWRTR  
Caca-MHCIexon3-pseudo*16 .P.....................................................SGRWPVRRRAIGSTWRTR  
Caca-MHCIexon3-pseudo*17 ...........................................DRGGHRGADHTPQ.................  
Caca-MHCIexon3-pseudo*18 ...........................................DRGGHRGADHTPQ.......V.........  
Caca-MHCIexon3-pseudo*19 ...........................................DRGGHRGADHTPQV......V.........  
Caca-MHCIexon3-pseudo*20 ...N..WTY................VS...K...S..K.....DRSGHRGADHPPQVGGGLCGG.HQELPGGH 
Figure 3. Amino acid translations of the unique MHC class I exon 3 alleles detected in this study. 
Dots and single letters designate nucleotide bases identical to and different from the first allele 
respectively. Asterisks represent stop codons. Sites with a + indicate previously reported amino 




The final class I sequence alignment for each exon together with published sequences from 
other carnivores, including felids, are reported in Appendix A and B. For each exon a sub-set 
of representative sequences were used to construct phylogenetic trees, comprising 19 exon 2 
alleles (Figure 4) and 21 exon 3 alleles (Figure 5). Two clades characterized the evolutionary 
relationships of both exons. Clade one, in both analyses, is comprised of highly similar 
sequences from caracal and a number of related felid species, including domestic cat, 
Geoffroy’s cat (Leopardus geoffroyi), sand cat (Felis margarita), golden cat (Catopuma 
temminckii), margay (Leopardus wiedii) and Pallas’s cat (Otocolobus manul). Clade two 
includes sequences from caracal and related species, but with substantially longer branch 
lengths, reflecting their higher overall levels of nucleotide variation. 
Positive selection at exon 2 and exon 3 of caracal MHC class I loci 
The positive selection test, modelled on the theory that positive selection enhances the rate of 
nonsynonymous codon substitutions compared with that of synonymous ones, revealed 
evidence for positive selection within the PBR codons of exon 3 (Table 4). In fact, the 
comparison of only PBR exon 3 codons displayed over twice as many nonsynonymous 
substitutions as synonymous ones (ω = dN/dS = 2.373), although the difference was not 
statistically significant (one sided z-test; Z = 1.179 p = 0.120). Evidence for positive selection 
was not detected in the full sequences or non-PBR codons in both exon 2 and exon 3. 
Additionally, the PBR codons in exon 2 did not show an excess of nonsynonymous changes 
(ω = dN/dS = 0.846).  
Table 4. Mean genetic distances* of synonymous (dS) and nonsynonymous (dN) substitutions in 
putatively functional MHC class I exon 2 and exon 3 alleles in caracal. 
 
dS ± SD dN ± SD ω = dN/dS p 
Exon 2 
    All codons 0.074 ± 0.068 0.065 ± 0.068 0.878 1.000 
PBR only 0.227 ± 0.299 0.192 ± 0.247 0.846 1.000 
Non-PBR only 0.053 ± 0.042 0.038 ± 0.032 0.717 1.000 
Exon 3 
    All codons 0.097 ± 0.095 0.065 ± 0.058 0.670 1.000 
PBR only 0.075 ± 0.091 0.178 ± 0.201 2.373 0.120 
Non-PBR only 0.100 ± 0.099 0.050 ± 0.040 0.500 1.000 
*Calculated by the Nei & Gojobori (1986) method with Jukes-Cantor corrections. The p-value of 
the Z test is reported, with a null hypothesis dN/dS ≤ 1. 
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Figure 4. Phylogenetic placement of caracal MHC class I exon 2 alleles and related species 
using neighbour-joining tree construction and rooted with domestic dog and two seal species. 




Figure 5. Phylogenetic placement of caracal MHC class I exon 3 alleles and related species 
using neighbour-joining tree construction and rooted with domestic dog and European badger. 




Influence of exon 2 alleles and diversity on Babesia prevalence 
Individuals free of Babesia infection (n = 3) had 2-3 MHC class I exon 2 alleles, while 
individuals that were infected (n = 23) had between two and six. This difference between the 
numbers of alleles of infected (mean = 3.3 ± 1.3 SD) and uninfected (mean = 2.3 ± 0.6 SD) 
individuals was not statistically significant (Table 5). Gene diversity within each individual’s 
allele repertoire also did not have a significant effect on whether the individual was infected 
or uninfected with Babesia (χ2 = 1.089, p = 0.297). However, both nucleotide diversity and 
average number of nucleotide differences in individuals’ exon 2 alleles were found to have a 
significant effect on Babesia infection (χ2 = 5.628, p = 0.018; χ2 = 6.471, p = 0.011 
respectively). On average, infected individuals had a higher nucleotide diversity (0.040 ± 
0.025) and average number of nucleotide differences (7.5 ± 4.7 SD) than uninfected 
individuals. 
Influence of exon 3 alleles and diversity on Babesia prevalence 
All genetic diversity measures of MHC class I exon 3 had significant associations with 
Babesia prevalence (Table 5). On average, infected individuals possessed nearly double the 
number of exon 3 alleles (mean = 4.4 ± 1.8 SD) that uninfected individuals had (mean = 2.3 ± 
1.2 SD). In addition, higher gene diversity, nucleotide diversity and average number of 
nucleotide differences were associated with Babesia infection. In fact, the latter two diversity 
measures showed highly significant differences between infected and uninfected individuals 
(p = 0.003). 
Specific MHC class I alleles and pathogen prevalence 
At both exon 2 and exon 3, one allele was found to be extremely common throughout the 
population, while the majority of alleles were very rare. The most common allele at exon 2, 
Caca-MHC1-exon2*01, was detected in every individual of the study population; and at exon 
3, Caca-MHC1-exon3*01 occurred in 25 out of 26 individuals. Three alleles, Caca-MHC1-
exon2*36, Caca-MHC1-exon3*12, and Caca-MHC1-exon3*37, occurred at intermediate 
frequencies in the population (0.54, 0.23 and 0.46 respectively) and were tested for their 
effect on Babesia prevalence. All other alleles isolated in this study occurred in less than 8% 
(one or two individuals) of the population. A significant correlation between two specific 
alleles and presence of Babesia was observed. Probability of a Babesia infection for 
individuals carrying Caca-MHC1-exon2*36 (χ2 = 5.101, p = 0.024) or Caca-MHC1-
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exon3*37 (χ2 = 4.048, p = 0.044) was significantly higher than those that did not carry the 
alleles (Figure 6). These alleles were not exclusively inherited together, as only nine 
individuals carried both within the same sequence (frequency = 0.35). Interestingly, when 
analysed as full sequences i.e. exon 2 and exon 3 for each individual sequence, the 
probability of Babesia infection for individuals carrying a sequence with both Caca-MHC1-
exon2*36 and Caca-MHC1-exon3*37 was not significantly different from individuals 
without both alleles (χ2 = 2.753, p = 0.097). The difference between the probability of 
infection for individuals with the Caca-MHC1-exon3*12 allele and those without it was also 
not statistically significant (χ2 = 1.688, p = 0.194). 
Table 5. Genetic diversity variables for individuals that were infected (n = 23) and uninfected     
(n = 3) with Babesia. Measures of home range and urban area cover in home range for infected 
(n = 20) and uninfected individuals (n = 1) are also included. Mean values, standard deviations 





(mean ± SD) 
Uninfected 
(mean ± SD) p Significance  
Exon 2 
    No. of alleles 3.3 ± 1.3 2.3 ± 0.6 0.118 - 
Gene diversity 0.652 ± 0.167 0.530 ± 0.342 0.297 - 
Nucleotide diversity 0.040 ± 0.025 0.008 ± 0.003 0.018 * 
Avg. no. of nucleotide differences 7.539 ± 4.728 1.111 ± 0.631 0.011 * 
Exon 3 
    No. of alleles 4.4 ± 1.8 2.3 ± 1.2 0.038 * 
Gene diversity 0.746 ± 0.137 0.465 ± 0.303 0.018 * 
Nucleotide diversity 0.034 ± 0.025 0.003 ± 0.002 0.003 ** 
Avg. no. of nucleotide differences 7.419 ± 5.535 0.611 ± 0.419 0.003 ** 
Home range 50.1 ± 49.4 202 0.274 - 
Urban area cover in home range 6.6 ± 6.5 2.2  0.369 - 




Figure 6. Probability of infection (mean ± SE) by Babesia in caracal that carry the following 
specific alleles: Caca-MHC1-exon2*36, Caca-MHC1-exon3*12, Caca-MHC1-exon3*37. P = 
presence of allele, A = absence of allele. p-values and significance codes (*p < 0.05) are shown. 
Sex, age, home range, urban area cover, and pathogen prevalence 
To investigate factors that influence infection rates beyond adaptive genetic variation, sex 
and age class were included in additional GLMs. The sex of individuals did not demonstrate 
a significant influence on infection with Babesia. While the probability of Babesia infection 
was higher for males (probability = 1.0) than for females (probability = 0.875), the difference 
was not significant (χ2 = 1.882, p = 0.170). The age class analysis categorized individuals as 
adults or sub-adults, excluding one kitten. The probability of infection was 0.95 for adults 
and 0.83 for sub-adults; although again, the results were not statistically significant (χ2 = 
0.696, p = 0.404). 
Home range size (mean = 50.1 km2 ± 49.4 SD) and cover of urban areas within home ranges 
(mean = 6.59 km2 ± 6.49 SD) was quite variable between the 21 individuals for which data 
was available. However, the distribution of detected pathogens was highly similar between 
these individuals, with only one individual free of Babesia infection, one free of Anaplasma 
infection, one with a Mycoplasma infection and zero with a Hepatozoon infection. This lack 
of variability of infections and limited sample size may have contributed to the lack of 
statistically significant findings. Neither home range (χ2 = 1.197, p = 0.274) nor extent of 

























P                   A                     P                  A                    P                A 
 Caca-MHC1-exon2*36        Caca-MHC1-exon3*12       Caca-MHC1-exon3*37 
p = 0.024 *                     p = 0.194            p = 0.044 * 
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Discussion 
MHC class I diversity and selection trends in the caracal 
The importance of the MHC in population and individual susceptibility to pathogens makes it 
valuable to include in studies of adaptive potential (Sommer 2005; Spurgin & Richardson 
2010; Blanchong et al. 2016). Although MHC diversity has been characterized in many felid 
species, diversity at class I loci remains understudied. This study provides the first 
comprehensive evaluation of MHC class I diversity in the caracal. Through examining 
diversity at the exons involved in binding and presenting foreign peptides to the immune 
system, and its association with individual Babesia prevalence, a number of interesting 
findings were revealed. Out of 312 clone sequences isolated from 26 individuals, 38 and 45 
unique, putatively functional alleles were identified from exon 2 and exon 3 respectively. A 
number of alleles with differing nucleotide sequences contained only synonymous 
substitutions, which do not cause changes when translated into amino acids, resulting in the 
detection of 31 (exon 2) and 43 (exon 3) unique amino acid sequences. The number of alleles 
observed per individual suggests the presence of a minimum of four functional class I loci in 
the caracal. Because the number of clones sequenced per individual was limited to 12-15, a 
conservative approach was used for quantifying the number of unique alleles; these results 
may therefore slightly underestimate the true number of MHC class I alleles and loci present 
in the species. Nevertheless, these findings do correspond to estimates reported in previously 
published literature on felid MHC class I loci; Yuhki et al. (2008) reported three in the 
domestic cat (felis catus), Castro-Prieto et al. (2011a) identified three in the cheetah 
(Acinonyx jubatus), Sachdev et al. (2005) identified five in the Asiatic lion (Panthera leo 
persica), and Pokorny et al. (2010) reported four in the Bengal tiger (Panthera tigris tigris). 
Phylogenetic analyses of caracal class I sequences revealed (i) close evolutionary affinity 
with published class I felid sequences and (ii) the presence of two clades, both of which 
comprise caracal sequences together with sequences from other felid species. These two 
clades are characterised by distinct amino acid profiles, which can be seen very clearly in 
Figure 4 and Figure 5. In both exon analyses, the first clade is comprised of highly similar 
sequences from the caracal and related species. This finding is in agreement with Smith and 
Hoffman’s (2001) analysis of MHC class I sequences isolated from three different felid 
lineages, where the authors report an allele shared by all three lineages analysed in their study 
(pantherine, domestic cat and ocelot), and part of which was also isolated in this study (Caca-
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MHC1-exon3*01). A more detailed analysis of felid MHC class I genes is clearly required to 
gain a more comprehensive understanding of evolutionary patterns of diversification and 
possible gene conversion events. 
Despite exon 2 and exon 3 together encoding the functionally important peptide binding sites 
of MHC class I, few published studies on felids have examined both exons. Those that have 
studied both generally observed higher polymorphism in exon 2 than in exon 3 (e.g. domestic 
cat, Yuhki & O’Brien 1994; Asiatic lion, Sachdev et al. 2005; and Bengal tiger, Pokorny et al. 
2010). However, the present study detected higher diversity at exon 3 in caracal, particularly 
within the peptide binding sites. In addition, evidence for positive selection was only 
identified in the functionally important amino acid residues of the exon 3 PBR. Although this 
result was not statistically significant, it does suggest some degree of positive selection likely 
acts on the functionally important codons in caracal MHC class I exon 3, and that variation at 
exon 3 may be more important for caracal MHC class I function than studies of related 
species have suggested. The ratio of non-synonymous to synonymous substitutions in exon 2 
was highly similar when analysed for all codons and the PBR codons only, and both ratios 
were relatively high (ω > 0.8). Nevertheless, no evidence of positive selection was detected 
in these regions. Interestingly, these results are very different from those of the Bengal tiger, 
within which highly significant evidence for selection in the exon 2 PBR was observed 
(Pokorny et al. 2010). 
Association between high MHC class I diversity measures and Babesia prevalence 
Pathogen screening of the population revealed that caracal of Cape Town have high levels of 
infection by a number of tick-borne blood pathogens. No individual tested was free of any 
infections. Many individuals (n = 23) tested positive for multiple infections, a pattern that has 
been observed in other studies of pathogen prevalence in South African felid populations 
(Penzhorn et al. 2006; Bosman et al. 2007). In addition, there was little variation in the 
pathogen prevalence across the population, limiting the extent to which a GLM framework 
could be used to explore the influence of MHC variation, and other interacting factors, on 
infection by certain pathogens. Despite this, multiple measures for MHC class I diversity 
were significantly associated with the prevalence of Babesia. Infection with Babesia was 
linked with higher exon 2 diversity (nucleotide diversity and average number of nucleotide 
differences) and exon 3 diversity (number of alleles, gene diversity, nucleotide diversity and 
average number of nucleotide differences) relative to that of uninfected individuals. Although 
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low diversity is often assumed to contribute to pathogen susceptibility, there are a number of 
possible explanations for an association between high diversity and pathogen infection. 
Firstly, several studies have argued that maximal numbers of MHC allelic diversity does not 
result in the highest individual fitness levels (Nowak et al. 1992; Wegner et al 2003). This is 
due to the interaction of MHC molecules and T-cell receptors, which drives an 
immunological compromise between the numbers of expressed MHC molecules and T-cell 
receptors. The expression of too many MHC molecules causes an overall loss of T-cell 
receptors through the thymic selection process, which can lead to the presentation of too 
many self-derived peptides, leading to inhibition of overall pathogen recognition efficiency 
(Lawlor et al. 1990; Nowak et al. 1992; Wegner et al 2003). The pressure of opposing 
selective forces (thymic and positive) acting on MHC likely favours an intermediate level of 
individual MHC diversity (Nowak et al. 1992). Indeed, experimental evidence has 
demonstrated that an intermediate level of MHC diversity can correspond to the highest 
levels of fitness in the face of multiple parasites (Wegner et al. 2003b). Thymic selection is 
likely to contribute to an optimum number of MHC class I alleles in natural populations, but 
very little is known about it in non-model organisms. 
Association between specific MHC class I alleles and Babesia prevalence 
Another point to consider is the effect of specific alleles or specific allele combinations on 
pathogen susceptibility, which may be more important than overall levels of MHC diversity. 
Numerous studies have found evidence for the influence of one or more specific MHC alleles 
on both pathogen resistance and pathogen susceptibility (Schad et al. 2005; Bonneaud et al. 
2006; Loiseau et al. 2008). It is possible that expressing more total alleles increases the 
chance of having a specific allele that is associated with higher probability of infection. In 
this study, alleles Caca-MHC1-exon2*36 and Caca-MHC1-exon3*37 were both linked to a 
significant increase in the probability of Babesia infection. These alleles were found in 
approximately 54% (n = 14) and 46% (n = 12) of the population sample respectively. These 
sequences are not exclusively inherited together i.e. only nine individuals carried both alleles 
simultaneously. When full sequences were analysed for each individual, there was no 
significant effect of carrying both alleles. The majority of unique alleles detected in this study 
were rare, found in only one or two individuals, and were at frequencies that were too low for 
statistical analysis of their effects on immunocompetence. A wide variation in the distribution 
of alleles was also shown in the domestic cat MHC Class II (Addie et al. 2004). Additional 
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sampling of caracal could help determine whether any of these rare alleles do relate to 
pathogen resistance.  
An alternative explanation for the observed positive relationship between high MHC 
diversity and specific alleles with pathogen infection is that high variation and/or specific 
alleles might contribute to individuals surviving infection. In such a case, caracal that have a 
large number of alleles, or specifically carry alleles Caca-MHC1-exon2*36 or Caca-MHC1-
exon3*37, may be better at tolerating infections; whereas caracal that do not carry the alleles 
more often succumb to infections and their lethal effects. Unfortunately, an analysis of 
cellular indicators of immune response and stress was not part of this study. However, future 
research that includes cellular measures of health might reveal interesting associations 
between the MHC and infection tolerance. This type of analysis could be especially 
informative in Cape Town, where the caracal population appears to support a large number of 
individuals with multiple infections of tick-borne pathogens.  
Multiple drivers of pathogen prevalence in wild populations 
It is important to remember that a range of variables interacts to influence pathogen 
prevalence in wild populations; these include genetic diversity, environmental conditions and 
population history. The influence of sex and age class was therefore also investigated, but 
showed no significant effect on Babesia prevalence in the population. This suggests that sub-
adult males do not have an increased risk of pathogen exposure despite frequently being 
pushed to smaller, suboptimal edges of habitat by larger, territorial adults (L. Serieys, 
unpublished data). Testing for infection by a range of additional pathogens, and in more 
individuals, would clearly contribute to a more thorough exploration of the role of age and 
gender on patterns of individual infection.  
Exposure to urban and agricultural landscapes versus natural habitat influences the 
probability of exposure to ticks and thereby infection by tick-borne pathogens in host 
populations (Bevins et al. 2012; Rizzoli et al. 2014; Mackenstedt et al. 2015). The lack of 
individual variation in infections within Cape Town’s caracal population, yet distinct 
infection trend compared with populations in natural and agricultural areas, suggests that the 
environment is likely to be an important factor in determining pathogen prevalence for 
caracal in South Africa. Unfortunately, there is scant information about the tick loads in the 
environments across these regions. In addition, seasonal changes in tick loads together with 
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differing tolerance levels by host species make it difficult to assess the overall disease 
pressure on populations (Mackenstedt et al. 2015). Despite this limitation, studies have found 
that use of urban areas can increase the risk of disease exposure for carnivore populations 
(Riley et al. 2004). With this in mind, home range size together with the proportion of urban 
cover in an individual’s home range were used as ecological proxies to test for any 
relationship between pathogen prevalence and landscape. No significant effect of these 
factors was detected, although a larger sample size is required to better assess the role of 
landscape in patterns of infection. 
While a larger sample size might overcome some of the limitations of the current dataset, the 
results also highlight the need for future studies to examine pathogen burden and MHC 
variation over time. Because wild populations are exposed to frequent environmental 
fluctuations, host-pathogen interactions, as well as subsequent selection pressure, 
significantly vary with time (Hedrick 2002). Although long-term studies of the MHC in wild 
populations are scarce, fluctuating selection has been observed within the Soay sheep (Ovis 
aries) MHC class II, during a 13-year study (Charbonnel & Pemberton 2005). Additional 
long-term studies of adaptive genetic variation will contribute to a better understanding of the 
patterns of selection pressure for wild populations in rapidly transforming landscapes that 




This study assessed MHC class I variation in an urban population of caracal, and provides the 
first evaluation of the relationship between class I diversity and specific alleles on Babesia 
prevalence in a wild felid population. The adaptive genetic variation at the MHC provides an 
ideal subject for better understanding population susceptibility to pathogens in wild 
populations. Examination of this relationship in transformed, and particularly urban 
landscapes, is especially important in the face of rapid environmental change. Future studies 
that employ a similar approach will contribute to a more nuanced understanding of the ways 
adaptive genetic variation contributes to disease susceptibility, and will become increasingly 
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Figure S1. Alignment of the unique MHC class I exon 2 nucleotide sequences detected in this study, together with published sequences from 
related species used in phylogenetic analysis. Dots indicate shared identity with the first allele. 
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Caca-MHCIexon2*01            GACGACACGCAGTTCGTGCGGTTCGACACCGACGCCCCAAATCCGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGTGGGGCCAGAGTATTGGGACC  
Caca-MHCIexon2*02            .G..................................................................................................  
Caca-MHCIexon2*03            ....T...............................................................................................  
Caca-MHCIexon2*04            ....G...............................................................................................  
Caca-MHCIexon2*05            ............................................A............................G..........................  
Caca-MHCIexon2*06            ......G........................G....................................................................  
Caca-MHCIexon2*07            ....................................................................................................  
Caca-MHCIexon2*08            ................A...........G.........G..........................A..................................  
Caca-MHCIexon2*09            ...........................G........................................................................  
Caca-MHCIexon2*10            ........................................G...........................................................  
Caca-MHCIexon2*11            .............................A..........G...........................................................  
Caca-MHCIexon2*12            .......................................G................A...........................................  
Caca-MHCIexon2*13            .......................................................T............................................  
Caca-MHCIexon2*14            ......................................................................................G.........A...  
Caca-MHCIexon2*15            ....................................................................................................  
Caca-MHCIexon2*16            ....................................................................................................  
Caca-MHCIexon2*17            ....................................................................................................  
Caca-MHCIexon2*18            ....................................................................................................  
Caca-MHCIexon2*19            ....................................................................................................  
Caca-MHCIexon2*20            ....................................................................................................  
Caca-MHCIexon2*21            ....................................................................................................  
Caca-MHCIexon2*22            ....................................................................................................  
Caca-MHCIexon2*23            ....................................................................................................  
Caca-MHCIexon2*24            ....................................................................................................  
Caca-MHCIexon2*25            ..............T.....................................................................................  
Caca-MHCIexon2*26            ......................................G.............................................................  
Caca-MHCIexon2*27            ............................G.........G.............................................................  
Caca-MHCIexon2*28            ............................G.........G...........................................................T.  
Caca-MHCIexon2*29            ............................G.........G...................................A.........................  
Caca-MHCIexon2*30            ............................G.........G..........................A.............A......G.............  
Caca-MHCIexon2*31            ...............................................................................A......G.............  
Caca-MHCIexon2*32            ......G..........................................................A.............A......G.............  
Caca-MHCIexon2*33            ............................G.........G..........................A.............A......G.............  
Caca-MHCIexon2*34            ............................G.........G..........................A.............A......G.............  
Caca-MHCIexon2*35            ............................G.........G..........................A.............A......G.............  
Caca-MHCIexon2*36            ............................G.........G..........................A.............A......G.............  
Caca-MHCIexon2*37            ............................G.........G..........................A.............A......G.............  
Caca-MHCIexon2*38            ............................G.........G..........................A.............A......G.............  
Caca-MHCIexon2-pseudo*01     ............................G.........G..........................A.............A......G.............  
Caca-MHCIexon2-pseudo*02     ...........................................................................T........................  
Caca-MHCIexon2-pseudo*03     .................................................................................................... 
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Caracal caracal AF283072     ....................................T...............................................................  
Caracal caracal AF283078     ....................................................................................................  
Otocolobus manul AF283069    ....................................T...............................................................  
Felis catus AF283068         ....................................T...............................................................  
Felis catus AF283075         ....................................T................A..............................................  
Felis margarita AF283070     ....................................T...............................................................  
Catopuma temminckii AF283073 ....................................T...............................................................  
Leopardus wiedii AF283074    ....................................T...............................................................  
Oncifelis geoffroyi AF283071 ....................................T...............................................................  
Oncifelis geoffroyi AF283083 ............................G.A.......G..............................G.........A......G.............  
Leopardus pardalis AF283081  ..........................................................C.............C...T......A..C.....C......G  
Leopardus pardalis AF283082  ............................G.........G.....C...GAA....A..............................G.............  
Panthera pardus HQ318106     ............................G.........G......................T.................A......G.............  
Panthera pardus HQ318110     ............................G...T...............G...............A....T.........A........T...C.......  
Canis familiaris M32283      ............................G......GG.C.C.GG.........................G.........A......G.............  
Canis familiaris NM001014378 ...............C........A...G......GG.G.G.....A.G...............G..............A......G....T......GG  
Halichoerus grypus JX218935  ............................G....T.TGTC.G..A.........................G.........A......G.....C.......  
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Caca-MHCIexon2*01            GGGAGACGCGGATCGCCAAGGTGCACGCAGAGATTGCCCGACCGAACCTGCAGACCGCCCTCCGCTACTACAACCAGAGCGAGTCC  
Caca-MHCIexon2*02            ......................................................................................  
Caca-MHCIexon2*03            ..................................................................G...................  
Caca-MHCIexon2*04            ...................................................G..................................  
Caca-MHCIexon2*05            ...................................................G..................................  
Caca-MHCIexon2*06            ..........................A...........................................................  
Caca-MHCIexon2*07            ..........................T...........................................................  
Caca-MHCIexon2*08            ......................................................................................  
Caca-MHCIexon2*09            ..........................................................T...........................  
Caca-MHCIexon2*10            ......................................................................................  
Caca-MHCIexon2*11            ......................................................................................  
Caca-MHCIexon2*12            ......................................................................................  
Caca-MHCIexon2*13            ......................................................................................  
Caca-MHCIexon2*14            ......................................................................................  
Caca-MHCIexon2*15            ........................G.............................................................  
Caca-MHCIexon2*16            ..............................G.......................................................  
Caca-MHCIexon2*17            ............................................G.........................................  
Caca-MHCIexon2*18            ...............................................................T......................  
Caca-MHCIexon2*19            .................................................................C....................  
Caca-MHCIexon2*20            ........................................................A.....................A.......  
Caca-MHCIexon2*21            .......................................................................G.........T....  
Caca-MHCIexon2*22            .................................................................................G....  
Caca-MHCIexon2*23            ......................A...............................................................  
Caca-MHCIexon2*24            ..................................C...................................................  
Caca-MHCIexon2*25            ......................................................................T...............  
Caca-MHCIexon2*26            ......................................................................................  
Caca-MHCIexon2*27            ......................................................................................  
Caca-MHCIexon2*28            ......................................................................................  
Caca-MHCIexon2*29            ................................................C.....................................  
Caca-MHCIexon2*30            ......................................................................................  
Caca-MHCIexon2*31            A...........A..TG...AACTGG...C.....T.....GT.G.....A.C..GATG...........................  
Caca-MHCIexon2*32            A...........A..TG...AACTGG...C.....T.....GT.G.....A.CG.GATG...........................  
Caca-MHCIexon2*33            A....G......A..TG...AACTGG...C.....T.....GT.G.....A.C..GATG...........................  
Caca-MHCIexon2*34            A...........A..TG...AACTGG...C.....T.....GT.G.....A.C..GATG....A......................  
Caca-MHCIexon2*35            A...........A..TG...AACTGG...C.....T.....GT.G.....A.C..GATG........................C..  
Caca-MHCIexon2*36            A...........A..TG...AACTGG...C.....T.....GT.G.....A.C..GATG...........................  
Caca-MHCIexon2*37            A...........A..TG...AACTGG...C.....T.....GT.G.....A.C..GATG...........................  
Caca-MHCIexon2*38            A...........A..TG...AACAGG...C.....T.....GT.G.....A.C..GATG...........................  
Caca-MHCIexon2-pseudo*01     A...........A..TG...AACT.G...C.....T.....GT.G.....A.C..GATG...........................  
Caca-MHCIexon2-pseudo*02     ......................................................................................  










Caracal caracal AF283072     ......................................................................................  
Caracal caracal AF283078     ......................................................................................  
Otocolobus manul AF283069    ......................................................................................  
Felis catus AF283068         ......................................................................................  
Felis catus AF283075         ......................................................................................  
Felis margarita AF283070     ......................................................................................  
Catopuma temminckii AF283073 ......................................................................................  
Leopardus wiedii AF283074    ......................................................................................  
Oncifelis geoffroyi AF283071 ......................................................................................  
Oncifelis geoffroyi AF283083 A.....T.....C...G...AACA.....C...A.T.....GT.......A.C..GTTG...........................  
Leopardus pardalis AF283081  A.C.............G...AACAG....C...A.TT....G............................................  
Leopardus pardalis AF283082  ..A.C..C.....TTA.TT..ACAC....C.....TT....GT.G.....A.C..GATG...........................  
Panthera pardus HQ318106     ............A..TG...AACA.....C.....T.....GT.......A.C..GATG.......                      
Panthera pardus HQ318110     ............GG.T.....ACAC....C.....TT....GT..G......C..T..G...G...                      
Canis familiaris M32283      ..C.........C.AT.....A.AC....CG..C.TT....GT.G.....G.C...CTG.G.G...                      
Canis familiaris NM001014378 A.C.....GA..................CC...CCT.....T.C...........G......G...                      
Halichoerus grypus JX218935  ............ATCT.CG..ACGC....C...G..A....GT.G...........CTG.G.G...                      




Figure S2. Alignment of the unique MHC class I exon 3 nucleotide sequences detected in this study, together with published sequences 
from related species used in phylogenetic analysis. Dots indicate shared identity with the first allele. 
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Caca-MHCIexon3*01            GGGTCACACAGCATCCAGAGAATGCATGGCTGTGACATCGGGCCTGACGGACGCCTCCTCCGCGGGTACAGTCAGTTGGCCTACGACGGCGCGGATTACATCGCCCTGAA  
Caca-MHCIexon3*02            .A............................................T...............................................................  
Caca-MHCIexon3*03            ...C.....................................................................................T....................  
Caca-MHCIexon3*04            .........G.................................................................C..................................  
Caca-MHCIexon3*05            ................G.............................................................................................  
Caca-MHCIexon3*06            .......................T......................................................................................  
Caca-MHCIexon3*07            .......................A.............................................G........................................  
Caca-MHCIexon3*08            .....................................................................G........................................  
Caca-MHCIexon3*09            .................................A............................................................................  
Caca-MHCIexon3*10            ..................................G...........................................................................  
Caca-MHCIexon3*11            ..............................................................................................................  
Caca-MHCIexon3*12            ..............................................................................................................  
Caca-MHCIexon3*13            ..............................................................................................................  
Caca-MHCIexon3*14            .......................................................................................A......................  
Caca-MHCIexon3*15            ..........................................T...................................................................  
Caca-MHCIexon3*16            .................................................................................C............................  
Caca-MHCIexon3*17            .....................................................................................G........................  
Caca-MHCIexon3*18            ........................................................................................A.....................  
Caca-MHCIexon3*19            ...........................................................................................G..................  
Caca-MHCIexon3*20            ......................................................................................................A.......  
Caca-MHCIexon3*21            ............................................................................................A.................  
Caca-MHCIexon3*22            ..............................................................................................................  
Caca-MHCIexon3*23            ..............................................................................................................  
Caca-MHCIexon3*24            ..............................................................................................................  
Caca-MHCIexon3*25            ..............................................................................................................  
Caca-MHCIexon3*26            ..............................................................................................................  
Caca-MHCIexon3*27            ..............................................................................................................  
Caca-MHCIexon3*28            ..............................................................................................................  
Caca-MHCIexon3*29            ..............................................................................................................  
Caca-MHCIexon3*30            ..............................................................................................................  
Caca-MHCIexon3*31            .....G....A.......T.G.C.T.....................................................................................  
Caca-MHCIexon3*32            .....G....A.......T.G.C.T......................T..............................................................  
Caca-MHCIexon3*33            .......................................................................C...G..T....T......AA..........T.......  
Caca-MHCIexon3*34            .....G....A.......T.G.C.T......................T...........................G..T....T......AA..........T.......  
Caca-MHCIexon3*35            .....G....A.......T.G.C.T......................T...........................G..T....T......AA..........T.......  
Caca-MHCIexon3*36            .....G....A.......T.G.C.T......................T...........................G..T....T......AA..........T.......  
Caca-MHCIexon3*37            .....G....A.......T.G.C.T......................T...........................G..T....T......AA..........T.......  
Caca-MHCIexon3*38            .....G....A.......T.G.C.T.....C................T...........................G..T....T......AA..........T.......  
Caca-MHCIexon3*39            .....G....A.......T.G.C.T.C...................GT...........................G..T....T......AA..........T.......  
Caca-MHCIexon3*40            .....G....A.......T.G.C.T......................T...........................G..T..C.T......AA..........T.......   
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Caca-MHCIexon3*41            .....G....A.......T.G.C.T......................T...........................G..T....T......AA....C.....T.......  
Caca-MHCIexon3*42            .....G....A.......T.G.C.T......................T...........................G..T....T......AA..........T.......  
Caca-MHCIexon3*43            .....G....A.......T.G.C.T......................T...........................G..T....T......AA..........T.......  
Caca-MHCIexon3*44            .....G....A.......T.G.C.T......................T...........................G..T....T......AA..........T.......  
Caca-MHCIexon3*45            .....G....A.......T.G.C.TG.....................T...........................G..T....T......AA..........T...C...  
Caca-MHCIexon3-pseudo*01     ............................................................................A................................G  
Caca-MHCIexon3-pseudo*02     .....G....A.......T.G.C.T......................T...........................G..T....T......AA..........T.......  
Caca-MHCIexon3-pseudo*03     ..............................................................................................................  
Caca-MHCIexon3-pseudo*04     ..............................................................................................................  
Caca-MHCIexon3-pseudo*05     ..............................................................................................G...............  
Caca-MHCIexon3-pseudo*06     ...................................................................G..........................................  
Caca-MHCIexon3-pseudo*07     ..................................................T...........................................................  
Caca-MHCIexon3-pseudo*08     .......G......................................................................................................  
Caca-MHCIexon3-pseudo*09     .............................................................................................................G  
Caca-MHCIexon3-pseudo*10     ............G.................................................................................................  
Caca-MHCIexon3-pseudo*11     ..............................................................................................................  
Caca-MHCIexon3-pseudo*12     ..............................................................................................................  
Caca-MHCIexon3-pseudo*13     .......T.......................................................................................C..............  
Caca-MHCIexon3-pseudo*14     ........................................................A.....................................................  
Caca-MHCIexon3-pseudo*15     .................................................................................C............................  
Caca-MHCIexon3-pseudo*16     ...C..........................................................................................................  
Caca-MHCIexon3-pseudo*17     ..............................................................................................................  
Caca-MHCIexon3-pseudo*18     ....................G.........................................................................................  
Caca-MHCIexon3-pseudo*19     ..............................................................................................................  
Caca-MHCIexon3-pseudo*20     .....G....A.......T.G.C.T......................T...........................G..T....T......AA..........T....... 
Caracal caracal AF283089         ..........................................................................................................  
Caracal caracal AF283095         ..........................................................................................................  
Felis catus AF283085             ..........................................................................................................  
Felis catus AF283092             ................................G.........................................................................  
Otocolobus manul AF283086        ..........................................................................................................  
Felis margarita AF283087         ..........................................................................................................  
Catopuma temminckii AF283090     ..........................................................................................................  
Leopardus wiedii AF283091        ............................................................................T.............................  
Oncifelis geoffroyi AF283088     ..........................................................................................................  
Oncifelis geoffroyi AF283100     .G....C.T......C....T...........G.G..C..A...C.G...T..............T.G................C.............T.......  
Leopardus pardalis AF283098      .G.........................................TA........................T............T.................T.....  
Leopardus pardalis AF283099      .G....A......T......T.........................C.........T..............GAC.............G..................  
Panthera leo AY909995            .G....A.............T.C.........T.G.............A.................C.....G.........T.......................  
Panthera leo AY909928            .G....A.............T.C......................AC............A...........GAC.............A..................  
Panthera tigris HQ158004         .G....A.............T...........G....A..G.....C....................G...GA.T....T......AA..........T.......  
Leopardus pardalis AF283098      .G.........................................TA........................T............T.................T.....  
Leopardus pardalis AF283099      .G....A......T......T.........................C.........T..............GAC.............G..................  
Acinonyx jubatus GU971407        ..............T.G.CTT......................T...........................G..T....T......AA..........T.......  
Acinonyx jubatus GU971408        ..............T.G.CTT......................T...........................G..T....T......AA..........T.......  
Canis familiaris AF101511        .T....C........CC...T.C.........C.G.....C.G...G....................G...GAC..............C.................  
Canis familiaris AF101529        .T....C.CG.....CC...T.C.........C.G.....C.G...G....................G...GAC..............C.................  
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Caca-MHCIexon3*01            CGAGGACCTGCGCTCCTGGACCGCGGCGGACACCGCGGCGCAGATCACACGCCGCAAGTGGGAGGTGGCCGGTGAGGCGGCGCGCTATAGGAAGTACCTGGAGGACACG  
Caca-MHCIexon3*02            ..........................................A..................................................................  
Caca-MHCIexon3*03            .............................................................................................................  
Caca-MHCIexon3*04            .............................................................................................................  
Caca-MHCIexon3*05            .............................................................................................................  
Caca-MHCIexon3*06            .................................................................................A...........................  
Caca-MHCIexon3*07            .............................................................................................................  
Caca-MHCIexon3*08            .............................................................................................................  
Caca-MHCIexon3*09            ................................................................................T............................  
Caca-MHCIexon3*10            ................................................................................T............................  
Caca-MHCIexon3*11            ..................................A.............................................T............................  
Caca-MHCIexon3*12            ................................................................................T............................  
Caca-MHCIexon3*13            .................................................................A..............T............................  
Caca-MHCIexon3*14            ................................................................................T............................  
Caca-MHCIexon3*15            ..............................................................................A..............................  
Caca-MHCIexon3*16            ...........................................................................................................T.  
Caca-MHCIexon3*17            .............................................................................................................  
Caca-MHCIexon3*18            .............................................................................................................  
Caca-MHCIexon3*19            ..............................................................................................C..............  
Caca-MHCIexon3*20            ....................................................................T........................................  
Caca-MHCIexon3*21            ....................................................................T........................................  
Caca-MHCIexon3*22            ....................................................................T........................................  
Caca-MHCIexon3*23            .............C...............................................................................A...............  
Caca-MHCIexon3*24            ................C............................................................................................  
Caca-MHCIexon3*25            ........................................................G....................................................  
Caca-MHCIexon3*26            .......................................................G.....................................................  
Caca-MHCIexon3*27            ..................................................A..........................................................  
Caca-MHCIexon3*28            .............................................................................T.......G.......................  
Caca-MHCIexon3*29            ..........................................................................................A..................  
Caca-MHCIexon3*30            .......T................................................................................................G....  
Caca-MHCIexon3*31            .............................................T...............................................................  
Caca-MHCIexon3*32            ...........................................................................................G.................  
Caca-MHCIexon3*33            .A..........T...........A.......................C............................................................  
Caca-MHCIexon3*34            .A..........T...........A.......................C..........................A.................................  
Caca-MHCIexon3*35            .A..........T...........A.......................C................A....T...T..................................  
Caca-MHCIexon3*36            .A..........T...........A.......................C................A....T...T.....AAGA.GTC.....C..........G...A  
Caca-MHCIexon3*37            .A..........T...........A.......................C................A....T...T.....AAGA.ATC.....C..........G...A  
Caca-MHCIexon3*38            .A..........T...........A.......................C................A....T...T.....AAGA.ATC.....C..........G...A  
Caca-MHCIexon3*39            .A..........T...........A.......................C................A....T...T.....AAGA.ATC.....C..........G...A  
Caca-MHCIexon3*40            .A..........T...........A.......................C................A....T...T.....AAGA.ATC.....C..........G...A  
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Caca-MHCIexon3*41            .A..........T...........A.......................C................A....T...T.....AAGA.ATC.....C..........G...A  
Caca-MHCIexon3*42            .A......C...T......G....A........T..............C................A....T...T.....AAGA.ATC.....C..........G...A  
Caca-MHCIexon3*43            .A..........T...........A...................C...C................A....T...T.....AAGA.ATC.....C..........G...A  
Caca-MHCIexon3*44            .A..........T...........A.......................C....A...........A....T...T.....AAGA.ATC.....C..........G...A  
Caca-MHCIexon3*45            .A..........T...........A.......................C................A....T...T.....AAGA.ATC.....C..........G...A  
Caca-MHCIexon3-pseudo*01     ............................................................................................................. 
Caca-MHCIexon3-pseudo*02     .A..........T......GA.CGC.GC.GACA.CGC.GCGCAGATCACACG.CGC.AGT..GA.GT.G.C.GTGA.GC.GCGCGCTATA.G.AGTA.CT.GA.GACAC  
Caca-MHCIexon3-pseudo*03     ....................................................................G.C.GTGA.GC.GCGCGCTATA.G.AGTA.CT.GA.GACAC  
Caca-MHCIexon3-pseudo*04     ...................GA.CGC.GC.GACA.CGC.GCGCAGATCACACG.CGC.AGT..GA.GT.G.C.GTGA.GC.GCGCGCTATA.G.AGTA.CT.GA.GACAC  
Caca-MHCIexon3-pseudo*05     ...................GA.CGC.GC.GACA.CGC.GCGCAGATCACACG.CGC.AGT..GA.GT.G.C.GTGA.GT.GCGCGCTATA.G.AGTA.CT.GA.GACAC  
Caca-MHCIexon3-pseudo*06     ...................GA.CGC.GC.GACA.CGC.GCGCAGATCACACG.CGC.AGT..GA.GT.G.C.GTGA.GC.GCGCGCTATA.G.AGTA.CT.GA.GACAC  
Caca-MHCIexon3-pseudo*07     ...................GA.CGC.GC.GACA.CGC.GCGCAGATCACACG.CGC.AGT..GA.GT.G.C.GTGA.GC.GCGCGCTATA.G.AGTA.CT.GA.GACAC  
Caca-MHCIexon3-pseudo*08     ...................GA.CGC.GC.GACA.CGC.GCGCAGATCACACG.CGC.AGT..GA.GT.G.C.GTGA.GC.GCGCGCTATA.G.AGTA.CT.GA.GACAC  
Caca-MHCIexon3-pseudo*09     ........................................................GTG..AG.TG.C.G.TGAG.CG.CGCGCTATAG.A.GTAC.TG.AG.ACACGT  
Caca-MHCIexon3-pseudo*10     ..............................................T.........GTG..AG.TG.C.G.TGAG.CG.TGCGCTATAG.A.GTAC.TG.AG.ACACGT  
Caca-MHCIexon3-pseudo*11     ........................................................GTG..AG.TG.C.G.TGAG.CG.CGCGCTATAG.A.GTAC.TG.AG.ACACGT  
Caca-MHCIexon3-pseudo*12     ........................................................GTG..AG.TG.C.G.TGAG.CG.TGCGCTATAG.A.GTAC.TG.AG.ACACGT  
Caca-MHCIexon3-pseudo*13     ........................................................GTG..AG.TG.C.G.TGAG.CG.CGCGCTATAG.A.GTAC.TG.AG.ACACGT  
Caca-MHCIexon3-pseudo*14     ........................................................GTG..AG.TG.C.G.TGAG.CG.CGCGCTATAG.A.GTAC.TG.AG.ACACGT  
Caca-MHCIexon3-pseudo*15     ........................................................GTG..AG.TG.C.G.TGAG.CG.CGCGCTATAG.A.GTAC.TG.AG.ACACGT  
Caca-MHCIexon3-pseudo*16     ........................................................GTG..AG.TG.C.G.TGAG.CG.CGCGCTATAG.A.GTAC.TG.AG.ACACGT  
Caca-MHCIexon3-pseudo*17     ...................GA.CGC.GC.GACA.CGC.GCGCAGATCACACG.CGC....................................................T  
Caca-MHCIexon3-pseudo*18     ...................GA.CGC.GC.GACA.CGC.GCGCAGATCACACG.CGC........................T...........................T  
Caca-MHCIexon3-pseudo*19     ...................GA.CGC.GC.GACA.CGC.GCGCAGATCACACG.CGC.AGT....................T............................  
Caca-MHCIexon3-pseudo*20     .A..........T......GA.CGCAGC.GACA.CGC.GCGCAGATCAC.CG.CGC.AGT..GA.GA.G.CTGTGT.GC.GAA.AC..CA.G.ACTA.CT.GA.GGCAC 
Caracal caracal AF283089     .............................................................................................................  
Caracal caracal AF283095     ................................................................................T............................  
Felis catus AF283085         .............................................................................................................  
Felis catus AF283092         .............................................................................................................  
Otocolobus manul AF283086    .............................................................................................................  
Felis margarita AF283087     .............................................................................................................  
Catopuma temminckii AF283090 .............................................................................................................  
Leopardus wiedii AF283091    .............................................................................................................  
Oncifelis geoffroyi AF283088 .............................................................................................................  
Oncifelis geoffroyi AF283100 ..........A..........G....................................................T.....AAGA..TC.....C...GC.....G....  
Leopardus pardalis AF283098  T.........................................................................GT....A..AGG.G.....C...............  
Leopardus pardalis AF283099  .......T........................................................................A.....GG.....C..........G...A  
Panthera leo AY909995        .................................A..............C................AC.......T.....A..AGG.G.....C..............A  
Panthera leo AY909928        .......T.................................C.............................A........A.....GG.....C..........G...A  
Panthera tigris HQ158004     .................................A..............C................A..............A.....TG.....C..........G....  
Leopardus pardalis AF283098  T.........................................................................GT....A..AGG.G.....C...............  
Leopardus pardalis AF283099  .......T........................................................................A.....GG.....C..........G...A  
Acinonyx jubatus GU971407    .A......................A.......................C................A....T...T...C.AAGA.ATC.....C..........G....  
Acinonyx jubatus GU971408    .A......................A.......................C................A....T...T...C.AAGA.ATC.....C..........G....  
Canis familiaris AF101511    .................................G..............C..G.............C...A...ACT..A.A..A.G.......C.........ACG...  
Canis familiaris AF101529    ...............................G.G..............C..G...........A.C...A...ACT..A.A..A.CG......C.........ACG...  
Meles meles JQ425433         .................................G..............C.AG.............AC..G........A.A.....GG.....C..TG......G....!!
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Appendix C 
Table S1. Summary of MHC class I exon 2 and exon 3 diversity measures for each caracal individual 
included in this study. Diversity measures were calculated using DNAsp v5.10 (Librado & Rozas 2009). 
Individual 



















C1 4 0.89 0.06 11.3  6 0.85 0.06 13.1 
C2 3 0.55 0.04 8.2  5 0.85 0.06 13.0 
C3 3 0.76 0.05 8.6  7 0.77 0.05 10.5 
C4 6 0.68 0.05 8.9  3 0.77 0.03 6.0 
C5 3 0.85 0.01 1.8  1 0.17 0.00 0.2 
C6 2 0.49 0.07 12.6  4 0.73 0.07 15.1 
C7 2 0.30 0.04 7.9  7 0.67 0.02 5.2 
C8 4 0.88 0.01 1.4  4 0.44 0.00 0.6 
C9 2 0.49 0.07 12.6  6 0.94 0.04 8.7 
C10 5 0.80 0.07 13.5  6 0.88 0.07 15.7 
C11 3 0.68 0.03 5.2  3 0.68 0.03 5.7 
C12 3 0.82 0.05 8.7  3 0.74 0.04 9.6 
C13 3 0.44 0.05 8.3  2 0.73 0.01 1.1 
C16 3 0.58 0.01 1.2  3 0.73 0.00 0.9 
C17 2 0.46 0.00 0.5  7 0.91 0.01 1.8 
C18 2 0.17 0.01 0.8  3 0.46 0.00 0.7 
C19 2 0.46 0.03 4.7  3 0.58 0.03 6.9 
C20 2 0.65 0.04 7.7  3 0.74 0.04 9.7 
C21 3 0.80 0.07 12.8  7 0.89 0.07 16.2 
C22 4 0.80 0.07 12.8  5 0.73 0.04 9.6 
C24 6 0.88 0.08 15.1  3 0.76 0.07 15.5 
C25 2 0.68 0.00 0.8  1 0.58 0.00 0.8 
C26 2 0.58 0.00 0.7  3 0.77 0.01 1.0 
C27 3 0.58 0.01 1.0  3 0.85 0.01 1.3 
C28 6 0.77 0.05 8.7  5 0.91 0.01 3.0 
C29 4 0.58 0.01 1.0  5 0.46 0.00 0.7 
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